The raise comes after Kineta went public in December through a reverse merger with Boston-based biotech Yumanity Therapeutics Inc.
Click here to view original post
The raise comes after Kineta went public in December through a reverse merger with Boston-based biotech Yumanity Therapeutics Inc.
Click here to view original post
Copyright © 2023 Biotech Networks, LLC